LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 24 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $57,401,000 | +28.0% | 16,298,000 | 0.0% | 0.67% | +15.0% |
| Q2 2018 | $44,858,000 | -11.0% | 16,298,000 | -29.2% | 0.58% | -10.9% |
| Q1 2018 | $50,410,000 | +203.6% | 23,025,000 | +153.7% | 0.65% | +288.1% |
| Q4 2017 | $16,604,000 | -30.1% | 9,075,000 | -44.7% | 0.17% | -45.3% |
| Q4 2016 | $23,743,000 | -12.0% | 16,416,000 | -10.9% | 0.31% | -23.8% |
| Q3 2016 | $26,970,000 | -34.0% | 18,416,000 | -24.7% | 0.40% | -35.0% |
| Q2 2016 | $40,849,000 | +9.5% | 24,445,000 | 0.0% | 0.62% | -41.5% |
| Q1 2016 | $37,293,000 | -1.4% | 24,445,000 | 0.0% | 1.06% | +30.2% |
| Q4 2015 | $37,808,000 | +19.4% | 24,445,000 | 0.0% | 0.81% | +9.0% |
| Q3 2015 | $31,664,000 | – | 24,445,000 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opera Trading Capital | 5,700,000 | $8,208,000 | 2.47% |
| TFG Asset Management GP Ltd | 8,100,000 | $11,729,000 | 2.33% |
| Mint Tower Capital Management B.V. | 4,500,000 | $6,507,000 | 2.17% |
| BASSO CAPITAL MANAGEMENT, L.P. | 8,010,000 | $11,584,000 | 1.75% |
| CQS Cayman LP | 15,000,000 | $21,717,000 | 1.72% |
| LINDEN ADVISORS LP | 21,855,000 | $31,633,000 | 1.23% |
| CAMDEN ASSET MANAGEMENT L P /CA | 22,575,000 | $32,593,000 | 0.92% |
| Myriad Asset Management Ltd. | 9,000,000 | $13,045,000 | 0.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 25,000,000 | $36,172,000 | 0.64% |
| CSS LLC/IL | 5,500,000 | $7,955,000 | 0.43% |